Corcept Therapeutics Incorporated (NASDAQ:CORT) Eyes Short-Term Rebound Despite Regulatory Cloud
![]() |
Momentum indicators show short-term buying pressure, but a regulatory and legal overhang plus WMDST’s valuation call create asymmetric near-term risk. The company’s cash buffer and high margins support operations while clinical and legal headlines drive volatility. |








